HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of cyclizine and granisetron alone and in combination for the prevention of postoperative nausea and vomiting.

Abstract
We conducted a randomised double-blinded study of 960 women undergoing day-case surgery to determine whether combination anti-emetic therapy of granisetron and cyclizine was more effective at decreasing the incidence of postoperative nausea and vomiting than these agents used alone. The women were randomly allocated to three groups to receive intravenous granisetron 1 mg, cyclizine 50 mg or both before induction of general anaesthesia. The incidence of postoperative nausea and vomiting was 77/322 (24%) in the granisetron group, 73/316 (23%) in the cyclizine group and 53/322 (17%) in those women given both drugs (p = 0.04). There was no difference in the requirement for rescue anti-emetic drugs. There were no differences in the anaesthetic techniques used in the three groups. We conclude that the risk of postoperative nausea and vomiting is less with cyclizine and granisetron given together than with either given alone.
AuthorsR A Johns, J Hanousek, J E Montgomery
JournalAnaesthesia (Anaesthesia) Vol. 61 Issue 11 Pg. 1053-7 (Nov 2006) ISSN: 0003-2409 [Print] England
PMID17042842 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antiemetics
  • Cyclizine
  • Granisetron
Topics
  • Adult
  • Ambulatory Surgical Procedures
  • Antiemetics (adverse effects, therapeutic use)
  • Cyclizine (adverse effects, therapeutic use)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Granisetron (adverse effects, therapeutic use)
  • Humans
  • Postoperative Nausea and Vomiting (prevention & control)
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: